folic acid has been researched along with Neoplasms, Pleural in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christoph, DC; Flom, E; Kollmeier, J; Mairinger, FD; Mairinger, T; Popper, HH; Schmid, KW; Vollbrecht, C; Walter, RFH | 1 |
| Blatter, J; Burris, H; Gatzemeier, U; Keppler, U; Kindler, HL; Manegold, C; Rusthoven, JJ; Scagliotti, GV; Shin, DM; Symanowski, JT; Vasconcelles, MJ | 1 |
| Green, MR; Meyer, ML; Suwanrusme, H | 1 |
| Bunn, PA | 1 |
| Battesti, JP; Le Moan, G; Nidrecourt, A; Thuillier, A; Turiaf, J | 1 |
2 review(s) available for folic acid and Neoplasms, Pleural
| Article | Year |
|---|---|
Pemetrexed alone and in combination with platinum compounds in the management of malignant mesothelioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Dietary Supplements; Folic Acid; Folic Acid Antagonists; Glutamates; Guanine; Hematinics; Humans; Mesothelioma; Pemetrexed; Pleural Neoplasms; Vitamin B 12 | 2004 |
Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Folic Acid; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Mesothelioma; Pemetrexed; Pleural Neoplasms; Thymidylate Synthase; Vitamin B 12 | 2002 |
1 trial(s) available for folic acid and Neoplasms, Pleural
| Article | Year |
|---|---|
Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration Schedule; Female; Folic Acid; Folic Acid Antagonists; Follow-Up Studies; Glutamates; Guanine; Hematinics; Humans; Leukopenia; Male; Mesothelioma; Middle Aged; Neutropenia; Pemetrexed; Pleural Neoplasms; Survival Analysis; Treatment Outcome | 2003 |
2 other study(ies) available for folic acid and Neoplasms, Pleural
| Article | Year |
|---|---|
Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Female; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Peptide Synthases; Phenotype; Pleural Neoplasms; Prognosis; Reduced Folate Carrier Protein; Thymidylate Synthase; Treatment Outcome | 2017 |
[Significance of measuring the urinary excretion of folic acid for the diagnosis of lung and bronchial neoplasms].
Topics: Adenocarcinoma, Bronchiolo-Alveolar; FIGLU Test; Folic Acid; Folic Acid Deficiency; Hemoglobins; Humans; Methods; Myelography; Neoplasm Metastasis; Pleural Neoplasms; Respiratory Tract Neoplasms; Statistics as Topic | 1968 |